Stockscreener 앱 받기
2.03
0.98%
-0.02
Iczoom Group Inc 주식(IZM)의 최신 뉴스
ICZOOM Group (NASDAQ:IZM) Trading Up 0.5% – What’s Next? - Defense World
ICZOOM Group Inc. Regains Compliance with Nasdaq's Annual Shareholder Meeting Requirement - Longview News-Journal
ICZOOM Recognized Among Shenzhen Top 500 Enterprises List - The Eastern Progress Online
ICZOOM Attended 2024 International IC & Component Exhibition and Conference in Shenzhen - The Manila Times
ICZOOM Group Clinches Two Major Industry Awards at International IC Exhibition | IZM Stock News - StockTitan
ICZOOM Group Inc. Utilizes Nasdaq Exemptions - TipRanks
ICZOOM Filed the 20-F Amendment to Revise Certain Legal Risk Dis - GuruFocus.com
ICZOOM Group Inc. Reports Earnings Results for the Full Year Ended June 30, 2024 - Marketscreener.com
ICZOOM Successfully Exhibits and Achieves Resounding Success at - GuruFocus.com
ICZOOM Group (NASDAQ:IZM) Trading Down 1.4% – Should You Sell? - Defense World
Finansavisen - Finansavisen
IZM Stock Price and Chart — NASDAQ:IZM - TradingView
ICZOOM Ranked 49th Among Top Enterprise in China's 2024 Internet Industry and The CEO, Mr. Lei Xia, Recognized as One of 2024 China Internet Industry Leaders - Thailand Business News
ICZOOM Ranked 49th Among Top Enterprise in China's 2024 Internet Industry and The CEO, Mr. Lei Xia, - Digital More
Investcorp Credit Management BDC (ICMB) to Release Earnings on Wednesday - Defense World
Epoch Investment Partners Inc. Sells 218,352 Shares of Ichor Holdings, Ltd. (NASDAQ:ICHR) - Defense World
FDA Approves Miplyffa for Niemann-Pick Disease, Type C - MyChesCo
FDA Approves Miplyffa for Ultra Rare Niemann-Pick Disease Type C - Managed Healthcare Executive
Breon Corcoran Purchases 40,000 Shares of IG Group Holdings plc (LON:IGG) Stock - MarketBeat
FDA approves Zevra’s Miplyffa for Niemann-Pick disease type C treatment - World Pharmaceutical Frontiers
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease - Pharmaceutical Technology
FDA clears first drug for Niemann-Pick disease - pharmaphorum
Equities, commodities climb after China announces stimulus By Reuters - Investing.com
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease - Benzinga
Iofina reports robust first half results - Proactive Investors UK
Victory Capital Management Inc. Lowers Stake in Ichor Holdings, Ltd. (NASDAQ:ICHR) - Defense World
ICZOOM Successfully Exhibits and Achieves Resounding Success at ELEXCON 2024 Shenzhen International Electronics Expo - MSN
ICZOOM reports success at ELEXCON 2024 electronics expo By Investing.com - Investing.com Canada
ICZOOM Group Back in Nasdaq Compliance - TipRanks
ICZOOM Group Strengthens Governance and Flexibility - TipRanks
UPDATE: ICZOOM to Present at Benchmark Company's Annual Investor Conference - GuruFocus.com
ICZOOM Named to Influential 2023 China Top 100 Industrial Digita - GuruFocus.com
ICZOOM Group (NASDAQ:IZM) Trading Up 0.5% - Defense World
ICZOOM Group (NASDAQ:IZM) Stock Price Up 1.8% - Defense World
ICZOOM Group sets date for annual shareholder meeting - Investing.com
ICZOOM Group Calls Shareholders to Pivotal 2024 Meeting - TipRanks
ICZOOM Faces Nasdaq Noncompliance Issue - TipRanks
ICZOOM Group Inc. to Launch an Online Financing Program to Serve Small and Micro Enterprises - Barchart
ICZOOM Group Inc. (NASDAQ:IZM) Short Interest Up 10.7% in June - Defense World
ICZOOM to Present at H.C. Wainwright's 25th Annual Global Investment Conference - Quantisnow
ICZOOM Group Inc. Announces Change of Independent Auditor - Quantisnow
ICZOOM Announces Upgrade The Risk Control Of The SAAS System To Improve Service Quality And Security - Quantisnow
ICZOOM Group (NASDAQ:IZM) Stock Price Down 5.3% - Defense World
ICZOOM & WeBank signed the Supply Chain Finance Strategic Cooperation Agreement - PR Newswire
ICZOOM Group CFO Resigns, CEO Steps In - TipRanks
ICZOOM Filed the 20-F Amendment to Revise Certain Legal Risk Disclosures - PR Newswire
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
ICZOOM Announces Cancellation of Proposed Public Offering - PR Newswire
ICZOOM Group Inc.IZMby Martin SvandaShort Ideas - substack.com
IC Zoom Group Inc $IZM Explodes From $8 to $33.50 in 8 Days – The Herald - The Herald
ICZOOM Group (NASDAQ:IZM) Shares Up 25.3% - MarketBeat
ICZOOM Celebrates First Listing Anniversary on Nasdaq - Yahoo Finance
ICZOOM Group Inc.'s (NASDAQ:IZM) P/E Still Appears To Be Reasonable - Simply Wall St
ICZOOM Group Announces 1.32M Unit Offering at $9.08/unit - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Could The Market Be Wrong About ICZOOM Group Inc. (NASDAQ:IZM) Given Its Attractive Financial Prospects? - Yahoo Finance
Penn Entertainment results not so entertaining - 69News WFMZ-TV
Will Weakness in ICZOOM Group Inc.'s (NASDAQ:IZM) Stock Prove Temporary Given Strong Fundamentals? - Simply Wall St
ICZOOM Awarded Most Popular IPO Company with Investors - Yahoo Finance
0.77%
3.98%
자본화:
|
볼륨(24시간):